These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 2957943)

  • 1. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.
    Kemeny N; Daly J; Reichman B; Geller N; Botet J; Oderman P
    Ann Intern Med; 1987 Oct; 107(4):459-65. PubMed ID: 2957943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial.
    Safi F; Bittner R; Roscher R; Schuhmacher K; Gaus W; Beger GH
    Cancer; 1989 Jul; 64(2):379-87. PubMed ID: 2525415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
    Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G
    Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
    Lorenz M; Müller HH
    J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of extrahepatic disease during intraarterial floxuridine of colorectal liver metastases by simultaneous systemic 5-fluorouracil treatment? A prospective multicenter study.
    Lorenz M; Hottenrott C; Inglis R; Kirkowa-Reimann M
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3662-71. PubMed ID: 2531992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial.
    Rougier P; Laplanche A; Huguier M; Hay JM; Ollivier JM; Escat J; Salmon R; Julien M; Roullet Audy JC; Gallot D
    J Clin Oncol; 1992 Jul; 10(7):1112-8. PubMed ID: 1296590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
    Kemeny N; Huang Y; Cohen AM; Shi W; Conti JA; Brennan MF; Bertino JR; Turnbull AD; Sullivan D; Stockman J; Blumgart LH; Fong Y
    N Engl J Med; 1999 Dec; 341(27):2039-48. PubMed ID: 10615075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases.
    Chang AE; Schneider PD; Sugarbaker PH; Simpson C; Culnane M; Steinberg SM
    Ann Surg; 1987 Dec; 206(6):685-93. PubMed ID: 2961314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional infusion for colorectal hepatic metastases. A randomized trial comparing the hepatic artery with the portal vein.
    Daly JM; Kemeny N; Sigurdson E; Oderman P; Thom A
    Arch Surg; 1987 Nov; 122(11):1273-7. PubMed ID: 2960296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary results of a randomized study of intrahepatic infusion versus systemic infusion of 5-fluoro-2'-deoxyuridine for metastatic colorectal carcinoma.
    Kemeny N; Daly J
    Recent Results Cancer Res; 1986; 100():171-8. PubMed ID: 2942993
    [No Abstract]   [Full Text] [Related]  

  • 11. Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine.
    Hohn D; Melnick J; Stagg R; Altman D; Friedman M; Ignoffo R; Ferrell L; Lewis B
    J Clin Oncol; 1985 Jan; 3(1):98-102. PubMed ID: 3155548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver.
    O'Connell MJ; Nagorney DM; Bernath AM; Schroeder G; Fitzgibbons RJ; Mailliard JA; Burch P; Bolton JS; Colon-Otero G; Krook JE
    J Clin Oncol; 1998 Jul; 16(7):2528-33. PubMed ID: 9667274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.
    Hohn DC; Stagg RJ; Friedman MA; Hannigan JF; Rayner A; Ignoffo RJ; Acord P; Lewis BJ
    J Clin Oncol; 1989 Nov; 7(11):1646-54. PubMed ID: 2530317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump.
    Weiss GR; Garnick MB; Osteen RT; Steele GD; Wilson RE; Schade D; Kaplan WD; Boxt LM; Kandarpa K; Mayer RJ
    J Clin Oncol; 1983 May; 1(5):337-44. PubMed ID: 6199474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer.
    Kemeny N; Jarnagin W; Gonen M; Stockman J; Blumgart L; Sperber D; Hummer A; Fong Y
    J Clin Oncol; 2003 Sep; 21(17):3303-9. PubMed ID: 12947066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries.
    Kemeny MM; Goldberg D; Beatty JD; Blayney D; Browning S; Doroshow J; Ganteaume L; Hill RL; Kokal WA; Riihimaki DU
    Cancer; 1986 Feb; 57(3):492-8. PubMed ID: 2935243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial.
    Martin JK; O'Connell MJ; Wieand HS; Fitzgibbons RJ; Mailliard JA; Rubin J; Nagorney DM; Tschetter LK; Krook JE
    Arch Surg; 1990 Aug; 125(8):1022-7. PubMed ID: 2143063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer.
    Patt YZ; Boddie AW; Charnsangavej C; Ajani JA; Wallace S; Soski M; Claghorn L; Mavligit GM
    J Clin Oncol; 1986 Sep; 4(9):1356-64. PubMed ID: 2943876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary.
    Oberfield RA; McCaffrey JA; Polio J; Clouse ME; Hamilton T
    Cancer; 1979 Aug; 44(2):414-23. PubMed ID: 157798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer.
    Kemeny N; Cohen A; Seiter K; Conti JA; Sigurdson ER; Tao Y; Niedzwiecki D; Botet J; Budd A
    J Clin Oncol; 1993 Feb; 11(2):330-5. PubMed ID: 8426211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.